Investors potentially incurred losses because of securities broker Araya Mesfin [CRD: 4828859, Atlanta, Georgia], given the publicly available information found on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Mesfin worked for UBS Financial Services Inc. from January 13, 2014, to February 1, 2024, and has been registered with Morgan Stanley since January 18, 2024. Investors are encouraged to continue reading to find out more about the disclosures involving this securities broker.
Evidently, on February 13, 2026, a UBS Financial Services Inc. client filed FINRA Arbitration No. 26-00348 about Araya Mesfin. Mainly, the client alleged that Mesfin made unsuitable recommendations involving highly leveraged investments in triple net lease commercial real estate, failed to disclose material risks, facilitated unauthorized withdrawals to a third party, and participated in an outside business connected to the client’s investment. For this reason, the investor allegedly sustained damages associated with the commercial real estate investments. Therefore, the client requested $20,000,000 in compensation from UBS Financial Services Inc. or Mesfin. BrokerCheck shows that this arbitration is ongoing.
Specifically, a client of Morgan Stanley contested Araya Mesfin’s sales practices by filing FINRA Arbitration No. 26-00265 on February 4, 2026. Allegedly, Mesfin made unsuitable recommendations and violated Regulation Best Interest in connection with an investment strategy and a liquidity access line. It appears that Mesfin allegedly caused the client to sustain damages. Consequently, the client seeks compensation from Morgan Stanley or Mesfin in this ongoing matter.
Did you suffer any investment-related losses because of Araya Mesfin? If so, reach out to Soreide Law Group online or at (888) 760-6552 and talk to a securities lawyer regarding a potential recovery of your investment losses. Soreide Law Group has recovered losses for many investors throughout the United States. Also, our securities attorneys work on a contingency fee basis and advance all costs. Mesfin and brokerage firms Mesfin worked for deny any allegations of sales practice violations.
Contact Soreide Law Group for a Free Review of Your Potential Investment Loss Claim If your financial advisor recommended Creative Media & Community Trust (NASDAQ: CMCT) and you suffered substantial losses, you may have legal rights. A CMCT investment loss attorney can help you understand your options and pursue recovery. Many investors purchased CMCT believing […]
Soreide Law Group is investigating potential investor claims involving Cambridge Investment Research following a FINRA disciplinary action concerning Unit Investment Trust (UIT) recommendations. In April 2026, FINRA censured Cambridge Investment Research after finding supervisory deficiencies involving certain UIT recommendations made to retail clients. Investors who incurred excessive fees, unnecessary costs, or other damages associated with […]
Soreide Law Group is investigating potential investor claims involving Infinity Financial Services after FINRA sanctioned the firm for supervisory failures involving deferred variable annuity exchanges and recommendations. Investors who incurred surrender charges or other losses in connection with variable annuity transactions recommended through Infinity should review the allegations that led to FINRA's disciplinary action against […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com